Portfolio
Collective
Community
Team
Insights
Download our Term Sheet
Events
FAQ
Jobs
Privacy policy/GDPR
Whistleblower
Portfolio
January 8, 2024

Qvin's Q-Pad receives FDA clearance

In early January of 2024, Qvin made history; the FDA clearance of its Q-Pad and A1c Test marked the first FDA approval for menstrual blood health testing.

No items found.
Qvin's Q-Pad receives FDA clearance
No items found.
More about the author(s)
No items found.
More about the author(s)
No items found.

Related

February 9, 2026

Portfolio

Why we invested in Intric

The Sovereign AI Layer for Europe’s Public Sector

December 19, 2025

Portfolio

Why We Invested in Sumary

Sumary targets Europe’s accounting overhaul with AI-powered, automation-first software.

May 19, 2025

Portfolio

Why We Invested in Loki Robotics

We invested in Loki Robotics! Loki Robotics is building autonomous robots that clean like humans — starting with the messy, complex environments most robots can’t handle.

Sign up to our newsletter.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Get access to exclusive insights from our community of world-class founders and operators, delivered quarterly to your inbox. We process your personal data in accordance with our privacy policy.

Follow us